Products
Development ProgramsNanōmix is focused on collaborative development in two areas of its Sensation™ technology - a quantitative point-of-care platform for detecting biological molecules that can integrate immunoassays and metabolite testing, as well as continuous monitoring.Sensation technology offers a broad menu of applications for development, and several prototype devices are ready for strategic partnering opportunities. These include an ultrasensitive cardiac troponin assay to evaluate heart muscle damage, and the eNO Asthma Management System - a stand-alone breath analysis system for managing asthma that measures exhaled nitric oxide with accuracy of +/-2.5 ppb. Additionally, Sensation's gas and liquid detection capabilities enable the company's partners to access industrial product applications of its NanoTect™ Monitors under development. These include ultrasensitive detection of carbon monoxide, ammonia, and other gases, as well as biodefense applications that combine two CNT sensor platforms to simultaneously detect both trace explosives and biologicals. |
Product concept of Sensation™ CNT-based single-use disposable cartridge.
eNO Asthma Management System
(SEE THE VIDEO) |
